About 50 delegates from the World Health Organization (WHO) and eight countries and regions Wednesday attended a three-day meeting here to launch the First International Classification of Traditional Medicine (ICTM) project.
Participants are either practitioners or academics in disease terminology, classification or informatics. The project aims to develop an international standard set of harmonized terminology and classification for traditional medicine.
The event, entitled "First WHO Meeting on the International Classification of Traditional Medicine", is organized by the WHO with support from the Department of Health of Hong Kong.
Speaking at the opening ceremony, Hong Kong's Director of Health PY Lam said the project would go a long way to enhancing the integration of traditional medicine into the WHO Family of International Classifications which is crucial to the documentation on matters relating to traditional medicine.
"It is generally recognized that traditional medicine is increasingly popular worldwide. The ICTM will provide a platform for compiling healthcare statistics and information on traditional medicine which in turn can facilitate the study and evaluation of traditional medicine and documentation of its role in disease prevention and treatment," Lam said
Curcumin found in Turmeric is the key ingredient responsible for delaying liver damage. Curcumin renders the spice its bright yellow colour. In order to study Curcumin's role in delaying liver damage, the Austrian research team incorporated Turmeric in the diet of mice.
The mice were chemically induced with liver damage and fibrosis. For four and a half months, scientists observed the effects of curcumin on the mice with chronic liver inflammation before and after intake of diet enriched with Curcumin.
When scientists compared the tissue and blood sample results of these mice with those fed with a diet sans curcumin they found positive indications. Not only did the curcumin diet reduced bile duct blockage but also put a brake on liver cell (hepatocyte) damage and scarring (fibrosis). The mice fed with a normal diet did not show such results. "Targeting these pathways may be a promising therapeutic approach," say the authors, led by Michael Trauner.
The research on Turmeric and its liver related effects is still in a preliminary stage. The findings of this study led by Michael Trauner may well lead to a development of a new liver drug. Michael Trauner works at the Gastroenterology and Hepatology division at the Medical University Graz in Austria.
The goodness of Turmeric has been hailed since long by practitioners of Ayurveda.With this as one more added benefit of Turmeric, the value of the spice even goes higher! Not only is Turmeric a natural product but is also easy to use in day to day lives. Chronic cholangiopathies have no known effective treatments and in most cases liver transplant is the only option. In view of such complications, Turmeric and its benefits are indeed a boon.
A new pathological research has demonstrated that herbal medicine can lead to unwanted deaths, especially in people who consume too much of their natural remedies, or who combine such substances with prescription medication. University of Adelaide forensic pathologist Professor Roger Byard underlines the fact that many herbal chemicals have very toxic compounds inside, which can kill an adult on their own when taken in excessive quantities, or when combined with other chemicals from other drugs.
Naturopaths agree that there are dangers in herbal medicines for people who self-diagnose and then ''treat'' themselves with off-the-shelf products. However, they say the industry is generally well regulated.
The problem is compounded when herbs are contaminated, poorly processed or replaced with a cheaper alternative.
"These substances may cause serious illnesses, exacerbate pre-existing health problems or result in death, particularly if taken in excess or injected rather than ingested."
"Herbal medicines are frequently mixed with standard drugs, presumably to make them more effective. This can also have devastating results," Byard says.
Many common herbs could cause severe side effects when used with conventional medicine, such as negating the effect of blood-thinning agent warfarin or making epileptic seizures more frequent.
Ginkgo and garlic also increase the risk of bleeding with anticoagulants and certain herbal remedies such as Borage Oil and Evening Primrose Oil lower the seizure threshold in epileptics, said a university release.
''I'm not saying don't take them - herbal medicine is a time-honoured practice with real benefits,'' Professor Byard said. ''But you should talk to your doctor and work it out together.''
On a newly done research, Dr Shyam Mani Adhikari pointed out that there is no laboratory facility or well established mechanism for standardization and monitoring so far in Nepal to assure and control the quality of such medicines, many questions are raised regarding the quality, safety and efficacy of these medicines. Hence, substandard Ayurvedic medicines also might have been brought to the market which not only defames Ayurvedic physicians and decreases faith to the Ayurveda but also creates a risk of public health hazards.
He recommended that it requires very urgent and serious multi-dimensional attempts by concerned authorities and other stakeholders to manage and regulate this situation.
The benefits of marijuana in tempering or reversing the effects of Alzheimer's disease have been challenged in a new study by researchers at the University of British Columbia and Vancouver Coastal Health Research Institute.The findings, published in the current issue of the journal Current Alzheimer Research, could lower expectations about the benefits of medical marijuana in combating various cognitive diseases and help redirect future research to more promising therapeutics.
Previous studies using animal models showed that HU210, a synthetic form of the compounds found in marijuana, reduced the toxicity of plaques and promoted the growth of new neurons. Those studies used rats carrying amyloid protein, the toxin that forms plaques in the brains of Alzheimer's victims.
The new study, led by Dr. Weihong Song, Canada Research Chair in Alzheimer's Disease and a professor of psychiatry in the UBC Faculty of Medicine, was the first to test those findings using mice carrying human genetic mutations that cause Alzheimer's disease -- widely considered to be a more accurate model for the disease in humans.
"As scientists, we begin every study hoping to be able to confirm beneficial effects of potential therapies, and we hoped to confirm this for the use of medical marijuana in treating Alzheimer's disease," says Song, a member of the Brain Research Centre at UBC and VCH Research Institute and Director of Townsend Family Laboratories at UBC.
"But we didn't see any benefit at all. Instead, our study pointed to some detrimental effects."
Over a period of several weeks, some of the Alzheimer's-afflicted mice were given varying doses of HU210 -- also known as cannabinoids -- which is 100 to 800 times more potent than the marijuana compounds. Their memory was then tested.
The mice treated with HU210 did no better than untreated mice, with those given low doses of HU210 performing the worst. The researchers also found that HU210-treated mice had just as much plaque formation and the same density of neurons as the control group. The group given higher doses actually had fewer brain cells.
"Our study shows that HU210 has no biological or behavioural effect on the established Alzheimer's disease model," says Song, the Jack Brown and Family Professor and Chair in Alzheimer's Disease. "More studies should be done before we place much hope in marijuana's benefits for Alzheimer's patients."